(Reuters) -The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most ...

Medtronic initiated the recall of certain Pipeline Vantage embolisation devices in January 2025 following reports of four ...

Shares of Medtronic (NYSE:MDT) reached a session low on Tuesday after the U.S. Food and Drug Administration (FDA) announced a ...

In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...

Four of the 132 patients treated with Varipulse in the first two months of the U.S. launch had a form of stroke shortly after ...

Medtronic has issued an “Urgent Medical Device Correction” about the accuracy of insulin pump delivery during changes in air pressure, such as airplane takeoffs and landings. “We request you ...

The Medtronic Prevail drug coated balloon [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + announced results from a ...

Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success was offset by weaker sales from its medical-surgical business.

HYDERABAD Feb 25 (Reuters) - Medical device maker Medtronic (MDT.N), opens new tab is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U ...

Medtronic missed Wall Street's fiscal 2025 Q3 revenue estimate but beat earnings expectations. The company's revenue miss appears to be primarily related to a temporary change in distributor ...